Ann: Granting of New Research and Medicinal Cannabis Licences, page-2

ASX ANNOUNCEMENT
19
FEBRUARY
2018
GRANTING OF NEW RESEARCH AND MEDICINAL CANNABIS LICENCES

•New licences issued by the Office of Drug Controlahead of 12-month expiry of initial licences
•Matching permits issued
•Further secures Cann’s business plan as it scales up production through 2018

Cann Group Limited (ASX: CAN)has been granted two new licences by the Office of Drug Control (ODC) for the cultivation and production of cannabis for research and medicinal purposes.
The new Cannabis Research Licence and Medicinal Cannabis Licence were secured by Cann after it was required to reapply to the ODC (as per current legislation requirements), due to the expiry of the 12-month licences previously issued to the company.The corresponding permits to these licences
have also been issued including permits for cultivation relating to research activity, for the maintenance and use of mother plants and importantly, for cultivation and product for supply for therapeutic purposes.

Cann Group receives the new licences after proving its capability as a reliable medicinal
cannabis producer during 2017, having successfully completed multiple harvests of material.

As well as scaling up its production during 2018, the licences will allow the company to
continue its research and work with partners including La Trobe University, Aurora Cannabis, Agriculture Victoria, CSIRO and Anandia Labs.

Cann Group CEO Peter Crock said the new licences reinforce the pathway for the company into the coming years.

“We are continuing to scale up operations including our Northern Facility while also moving closer to securing a site and commencing construction
of our planned 16000m² Phase 3 facility,for which funding was secured last year,” he said.

“The granting of these new licences provides us with the security to continue to pursue our
business plan aggressively, including cannabis cultivation for both domestic demand as well as export opportunities.”

Cann Group was the first Australian company to be issued with the Cannabis Research Licence and Medicinal Cannabis Licence by the ODC in late February and early March 2017 respectively